Bt insecticides have decades of safe use with no clinical reports of adjuvanticity.

Bt Cry protein adjuvanticity studies have typically used systemic exposure routes.

Studies with inadequately characterized materials had limited interpretability.

Results were confounded by immunomodulatory contaminants/vehicle in protein preparations.

The overall evidence does not show Cry proteins to be oral adjuvants.